Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I randomized double-blind placebo-controlled single ascending dose study of TKT001-S in healthy Japanese males
jRCT2071230046Phase 1Completed
- Sponsor
- SEREN Pharmaceuticals
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing TKT001-S with Placebo (2 arms). Primary endpoints: Pharmacokinetics of TKT001-S, Safety of TKT001-S and 1 more. Started Sep 2023; status: completed.
02
Drugs
TKT001-S
Beyond the preview
Go deeper on jRCT2071230046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230046.